{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:55:23Z","timestamp":1781506523101,"version":"3.54.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2018MH028"],"award-info":[{"award-number":["ZR2018MH028"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2014HM020"],"award-info":[{"award-number":["ZR2014HM020"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30972778"],"award-info":[{"award-number":["30972778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cosmc (C1GalT1C1) mutation could cause aberrant <jats:italic>O<\/jats:italic>-glycosylation and result in expression of Tn antigen on the surface of tumor cells (Tn<jats:sup>+<\/jats:sup> cells), which is associated with the metastasis and prognosis of cancer progression. Mesenchymal stem cells (MSCs) could participate in immunoregulation, tissue damage repair, and tumor inhibition and be seen as an ideal candidate for tumor therapy due to their inherent capacity to migrate to tumor sites. However, their therapeutic effectiveness in different tumors is inconsistent and still controversial. Of note, emerging data reveal that side population (SP) cells have a stronger multilineage developmental potential than main population cells and can function as stem\/progenitor cells. The effect of SP cells derived from MSCs on the biological behaviors and the <jats:italic>O<\/jats:italic>-glycosylation status of tumor cells remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>SP cells were isolated from human umbilical cord MSCs (hUCMSCs) and human placenta MSCs (hPMSCs). Tn<jats:sup>+<\/jats:sup> cells (LS174T-Tn<jats:sup>+<\/jats:sup> and HT-29-Tn<jats:sup>+<\/jats:sup> cells) and matching Tn<jats:sup>\u2212<\/jats:sup> cells (LS174T-Tn<jats:sup>\u2212<\/jats:sup> and HT-29-Tn<jats:sup>\u2212<\/jats:sup> cells) were isolated from human colorectal cancer cell (CRC) lines LS174T and HT-29 by immune magnetic beads. The proliferation, migration, apoptosis, Tn antigen expression, and <jats:italic>O<\/jats:italic>-glycome in Tn<jats:sup>+<\/jats:sup> and Tn<jats:sup>\u2212<\/jats:sup> CRC cells before and after co-cultured with SP-MSCs were detected using real-time cell Analysis (RTCA), flow cytometry (FCM), and cellular <jats:italic>O<\/jats:italic>-glycome reporter\/amplification (CORA), respectively. Cosmc protein and <jats:italic>O<\/jats:italic>-glycosyltransferase (T-synthase and C3GnT) activity in CRC cells were, respectively, assessed using western blotting and fluorescence method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both SP cells derived from hUCMSCs and hPMSCs could inhibit proliferation and migration, promote apoptosis of CRC cells, significantly reduce Tn antigen expression on Tn<jats:sup>+<\/jats:sup> CRC cells, generate new core 1-, 2-, and 3-derived <jats:italic>O<\/jats:italic>-glycans,\u00a0increase T-synthase and C3GnT activity, and elevate the levels of Cosmc and T-synthase protein.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SP-hUCMSCs and SP-hPMSCs could inhibit proliferation and migration and promote apoptosis of Tn<jats:sup>+<\/jats:sup> CRC cells via increasing <jats:italic>O<\/jats:italic>-glycosyltransferase activity to modify <jats:italic>O<\/jats:italic>-glycosylation status, which further adds a new dimension to the treatment of CRC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03334-3","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:02:13Z","timestamp":1685124133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Side population cells derived from hUCMSCs and hPMSCs could inhibit the malignant behaviors of Tn+ colorectal cancer cells from modifying their O-glycosylation status"],"prefix":"10.1186","volume":"14","author":[{"given":"Wen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruisong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyou","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"issue":"2","key":"3334_CR1","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1080\/21655979.2021.2019173","volume":"13","author":"W You","year":"2022","unstructured":"You W, Di A, Zhang L, Zhao G. Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway. Bioengineered. 2022;13(2):2586\u201397.","journal-title":"Bioengineered"},{"issue":"5","key":"3334_CR2","doi-asserted-by":"publisher","first-page":"300060521100833","DOI":"10.1177\/03000605211008338","volume":"49","author":"X Pan","year":"2021","unstructured":"Pan X, Li B, Zhang G, Gong Y, Liu R, Chen B, et al. Identification of RORgamma as a favorable biomarker for colon cancer. J Int Med Res. 2021;49(5):3000605211008338.","journal-title":"J Int Med Res"},{"issue":"4","key":"3334_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264896","volume":"17","author":"F Meng","year":"2022","unstructured":"Meng F, Cao Y, Su H, Liu T, Tian L, Zhang Y, et al. Newcastle disease virus expressing an angiogenic inhibitor exerts an enhanced therapeutic efficacy in colon cancer model. PLoS ONE. 2022;17(4): e0264896.","journal-title":"PLoS ONE"},{"issue":"2","key":"3334_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.amjsurg.2016.01.025","volume":"212","author":"Z Moghadamyeghaneh","year":"2016","unstructured":"Moghadamyeghaneh Z, Hanna MH, Hwang G, Mills S, Pigazzi A, Stamos MJ, et al. Outcomes of colon resection in patients with metastatic colon cancer. Am J Surg. 2016;212(2):264\u201371.","journal-title":"Am J Surg"},{"issue":"12","key":"3334_CR5","doi-asserted-by":"publisher","first-page":"4902","DOI":"10.1007\/s00464-017-5544-7","volume":"31","author":"CEL Klaver","year":"2017","unstructured":"Klaver CEL, Kappen TM, Borstlap WAA, Bemelman WA, Tanis PJ. Laparoscopic surgery for T4 colon cancer: a systematic review and meta-analysis. Surg Endosc. 2017;31(12):4902\u201312.","journal-title":"Surg Endosc"},{"issue":"37","key":"3334_CR6","doi-asserted-by":"publisher","first-page":"60752","DOI":"10.18632\/oncotarget.11354","volume":"7","author":"G O'Malley","year":"2016","unstructured":"O\u2019Malley G, Heijltjes M, Houston AM, Rani S, Ritter T, Egan LJ, et al. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget. 2016;7(37):60752\u201374.","journal-title":"Oncotarget"},{"key":"3334_CR7","doi-asserted-by":"publisher","first-page":"7628763","DOI":"10.1155\/2018\/7628763","volume":"2018","author":"S Wang","year":"2018","unstructured":"Wang S, Miao Z, Yang Q, Wang Y, Zhang J. The dynamic roles of mesenchymal stem cells in colon cancer. Can J Gastroenterol Hepatol. 2018;2018:7628763.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"13","key":"3334_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3748\/wjg.v25.i13.1560","volume":"25","author":"MM El-Said","year":"2019","unstructured":"El-Said MM, Emile SH. Cellular therapy: a promising tool in the future of colorectal surgery. World J Gastroenterol. 2019;25(13):1560\u20135.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3334_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13287-020-01690-y","volume":"11","author":"X Yi","year":"2020","unstructured":"Yi X, Chen F, Liu F, Peng Q, Li Y, Li S, et al. Comparative separation methods and biological characteristics of human placental and umbilical cord mesenchymal stem cells in serum-free culture conditions. Stem Cell Res Ther. 2020;11(1):183.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3334_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nrm3049","volume":"12","author":"C Nombela-Arrieta","year":"2011","unstructured":"Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol. 2011;12(2):126\u201331.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5411","key":"3334_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143\u20137.","journal-title":"Science"},{"key":"3334_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-1-4939-2519-3_4","volume":"1293","author":"F Behbod","year":"2015","unstructured":"Behbod F, Vivanco MD. Side population. Methods Mol Biol. 2015;1293:73\u201381.","journal-title":"Methods Mol Biol"},{"issue":"2","key":"3334_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.stem.2011.01.007","volume":"8","author":"A Golebiewska","year":"2011","unstructured":"Golebiewska A, Brons NH, Bjerkvig R, Niclou SP. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell. 2011;8(2):136\u201347.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"3334_CR14","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","volume":"183","author":"MA Goodell","year":"1996","unstructured":"Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183(4):1797\u2013806.","journal-title":"J Exp Med"},{"issue":"12","key":"3334_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/nm1297-1337","volume":"3","author":"MA Goodell","year":"1997","unstructured":"Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, Paradis G, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3(12):1337\u201345.","journal-title":"Nat Med"},{"issue":"1","key":"3334_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2353\/ajpath.2010.090056","volume":"176","author":"K Kato","year":"2010","unstructured":"Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, et al. Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol. 2010;176(1):381\u201392.","journal-title":"Am J Pathol"},{"issue":"2","key":"3334_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/cells9020446","volume":"9","author":"R Gupta","year":"2020","unstructured":"Gupta R, Leon F, Rauth S, Batra SK, Ponnusamy MP. A systematic review on the implications of O-linked glycan branching and truncating enzymes on cancer progression and metastasis. Cells. 2020;9(2):446.","journal-title":"Cells"},{"key":"3334_CR18","doi-asserted-by":"publisher","first-page":"9532389","DOI":"10.1155\/2018\/9532389","volume":"2018","author":"X Dong","year":"2018","unstructured":"Dong X, Jiang Y, Liu J, Liu Z, Gao T, An G, et al. T-synthase deficiency enhances oncogenic features in human colorectal cancer cells via activation of epithelial-mesenchymal transition. Biomed Res Int. 2018;2018:9532389.","journal-title":"Biomed Res Int"},{"issue":"15","key":"3334_CR19","doi-asserted-by":"publisher","first-page":"12802","DOI":"10.1074\/jbc.M112457200","volume":"277","author":"T Iwai","year":"2002","unstructured":"Iwai T, Inaba N, Naundorf A, Zhang Y, Gotoh M, Iwasaki H, et al. Molecular cloning and characterization of a novel UDP-GlcNAc:GalNAc-peptide beta1,3-N-acetylglucosaminyltransferase (beta 3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans. J Biol Chem. 2002;277(15):12802\u20139.","journal-title":"J Biol Chem"},{"key":"3334_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-015-0386-1","volume":"14","author":"BT Hofmann","year":"2015","unstructured":"Hofmann BT, Schluter L, Lange P, Mercanoglu B, Ewald F, Folster A, et al. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Mol Cancer. 2015;14:109.","journal-title":"Mol Cancer"},{"issue":"10","key":"3334_CR21","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1111\/jcmm.13752","volume":"22","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Liu Z, Xu F, Dong X, Cheng Y, Hu Y, et al. Aberrant O-glycosylation contributes to tumorigenesis in human colorectal cancer. J Cell Mol Med. 2018;22(10):4875\u201385.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3334_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12885-018-4708-8","volume":"18","author":"X Sun","year":"2018","unstructured":"Sun X, Ju T, Cummings RD. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers. BMC Cancer. 2018;18(1):827.","journal-title":"BMC Cancer"},{"issue":"1","key":"3334_CR23","first-page":"197","volume":"49","author":"SH Itzkowitz","year":"1989","unstructured":"Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res. 1989;49(1):197\u2013204.","journal-title":"Cancer Res"},{"issue":"6","key":"3334_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/tan.12900","volume":"88","author":"C Fu","year":"2016","unstructured":"Fu C, Zhao H, Wang Y, Cai H, Xiao Y, Zeng Y, et al. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen. HLA. 2016;88(6):275\u201386.","journal-title":"HLA"},{"issue":"3","key":"3334_CR25","first-page":"2590","volume":"8","author":"X Yu","year":"2015","unstructured":"Yu X, Du Z, Sun X, Shi C, Zhang H, Hu T. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29. Int J Clin Exp Pathol. 2015;8(3):2590\u2013602.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"3334_CR26","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1158\/0008-5472.CAN-07-2345","volume":"68","author":"T Ju","year":"2008","unstructured":"Ju T, Lanneau GS, Gautam T, Wang Y, Xia B, Stowell SR, et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Res. 2008;68(6):1636\u201346.","journal-title":"Cancer Res"},{"issue":"1","key":"3334_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13287-021-02407-5","volume":"12","author":"A Zhang","year":"2021","unstructured":"Zhang A, Zhang J, Li X, Zhang H, Xiong Y, Wang Z, et al. hPMSCs inhibit the expression of PD-1 in CD4(+)IL-10(+) T cells and mitigate liver damage in a GVHD mouse model by regulating the crosstalk between Nrf2 and NF-kappaB signaling pathway. Stem Cell Res Ther. 2021;12(1):368.","journal-title":"Stem Cell Res Ther"},{"issue":"19","key":"3334_CR28","doi-asserted-by":"publisher","first-page":"23393","DOI":"10.18632\/aging.203633","volume":"13","author":"R Ding","year":"2021","unstructured":"Ding R, Hu X, Hu W, Du Z, Huang P, Wang M, et al. Cosmc transfection decreases malignant behavior of Tn(+) cells and enhances sensitivity to apoptosis when induced by Apo2L\/TRAIL via alteration of O-glycan structure. Aging (Albany NY). 2021;13(19):23393\u2013406.","journal-title":"Aging (Albany NY)"},{"key":"3334_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1042\/BSR20140031","volume":"34","author":"CM Dowling","year":"2014","unstructured":"Dowling CM, Herranz Ors C, Kiely PA. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Biosci Rep. 2014;34:4.","journal-title":"Biosci Rep"},{"issue":"3","key":"3334_CR30","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/glycob\/cwq168","volume":"21","author":"T Ju","year":"2011","unstructured":"Ju T, Xia B, Aryal RP, Wang W, Wang Y, Ding X, et al. A novel fluorescent assay for T-synthase activity. Glycobiology. 2011;21(3):352\u201362.","journal-title":"Glycobiology"},{"issue":"1","key":"3334_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nmeth.3675","volume":"13","author":"MR Kudelka","year":"2016","unstructured":"Kudelka MR, Antonopoulos A, Wang Y, Duong DM, Song X, Seyfried NT, et al. Cellular O-glycome reporter\/amplification to explore O-glycans of living cells. Nat Methods. 2016;13(1):81\u20136.","journal-title":"Nat Methods"},{"issue":"3","key":"3334_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/sctm.18-0117","volume":"8","author":"S Francois","year":"2019","unstructured":"Francois S, Usunier B, Forgue-Lafitte ME, L\u2019Homme B, Benderitter M, Douay L, et al. Mesenchymal stem cell administration attenuates colon cancer progression by modulating the immune component within the colorectal tumor microenvironment. Stem Cells Transl Med. 2019;8(3):285\u2013300.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"3334_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pin.12129","volume":"64","author":"S Wakao","year":"2014","unstructured":"Wakao S, Akashi H, Kushida Y, Dezawa M. Muse cells, newly found non-tumorigenic pluripotent stem cells, reside in human mesenchymal tissues. Pathol Int. 2014;64(1):1\u20139.","journal-title":"Pathol Int"},{"key":"3334_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-4-431-56847-6_18","volume":"1103","author":"W Young","year":"2018","unstructured":"Young W. Future of muse cells. Adv Exp Med Biol. 2018;1103:309\u201315.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"3334_CR35","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/jcmm.14117","volume":"23","author":"Z Liu","year":"2019","unstructured":"Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, et al. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23(3):2083\u201392.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3334_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12943-017-0597-8","volume":"16","author":"SM Ridge","year":"2017","unstructured":"Ridge SM, Sullivan FJ, Glynn SA. Mesenchymal stem cells: key players in cancer progression. Mol Cancer. 2017;16(1):31.","journal-title":"Mol Cancer"},{"key":"3334_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1756-8722-7-14","volume":"7","author":"Z Sun","year":"2014","unstructured":"Sun Z, Wang S, Zhao RC. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol. 2014;7:14.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"3334_CR38","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00262-020-02567-y","volume":"69","author":"K Sineh Sepehr","year":"2020","unstructured":"Sineh Sepehr K, Razavi A, Hassan ZM, Fazel A, Abdollahpour-Alitappeh M, Mossahebi-Mohammadi M, et al. Comparative immunomodulatory properties of mesenchymal stem cells derived from human breast tumor and normal breast adipose tissue. Cancer Immunol Immunother. 2020;69(9):1841\u201354.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"3334_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/stem.2269","volume":"34","author":"L Berger","year":"2016","unstructured":"Berger L, Shamai Y, Skorecki KL, Tzukerman M. Tumor specific recruitment and reprogramming of mesenchymal stem cells in tumorigenesis. Stem Cells. 2016;34(4):1011\u201326.","journal-title":"Stem Cells"},{"issue":"1","key":"3334_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/s12935-021-02300-4","volume":"21","author":"X Xuan","year":"2021","unstructured":"Xuan X, Tian C, Zhao M, Sun Y, Huang C. Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance. Cancer Cell Int. 2021;21(1):595.","journal-title":"Cancer Cell Int"},{"key":"3334_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-37184-5_3","volume":"1234","author":"H Atiya","year":"2020","unstructured":"Atiya H, Frisbie L, Pressimone C, Coffman L. Mesenchymal stem cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:31\u201342.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"3334_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/096368915X686841","volume":"24","author":"DC Ding","year":"2015","unstructured":"Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant. 2015;24(3):339\u201347.","journal-title":"Cell Transplant"},{"key":"3334_CR43","doi-asserted-by":"publisher","first-page":"8443","DOI":"10.2147\/CMAR.S209880","volume":"11","author":"J Yang","year":"2019","unstructured":"Yang J, Lv K, Sun J, Guan J. Anti-tumor effects of engineered mesenchymal stem cells in colon cancer model. Cancer Manag Res. 2019;11:8443\u201350.","journal-title":"Cancer Manag Res"},{"issue":"11","key":"3334_CR44","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.bbamcr.2018.08.002","volume":"1865","author":"X Fu","year":"2018","unstructured":"Fu X, Xie F, Gong F, Yang Z, Lv X, Li X, et al. Suppression of PTBP1 signaling is responsible for mesenchymal stem cell induced invasion of low malignancy cancer cells. Biochim Biophys Acta Mol Cell Res. 2018;1865(11):1552\u201365.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"10","key":"3334_CR45","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/gt.2008.39","volume":"15","author":"E Spaeth","year":"2008","unstructured":"Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 2008;15(10):730\u20138.","journal-title":"Gene Ther"},{"issue":"5","key":"3334_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.neo.2017.02.010","volume":"19","author":"H Takigawa","year":"2017","unstructured":"Takigawa H, Kitadai Y, Shinagawa K, Yuge R, Higashi Y, Tanaka S, et al. Mesenchymal stem cells induce epithelial to mesenchymal transition in colon cancer cells through direct cell-to-cell contact. Neoplasia. 2017;19(5):429\u201338.","journal-title":"Neoplasia"},{"issue":"1","key":"3334_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bbrc.2014.07.074","volume":"451","author":"Y Peng","year":"2014","unstructured":"Peng Y, Li Z, Yang P, Newton IP, Ren H, Zhang L, et al. Direct contacts with colon cancer cells regulate the differentiation of bone marrow mesenchymal stem cells into tumor associated fibroblasts. Biochem Biophys Res Commun. 2014;451(1):68\u201373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3334_CR48","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10549-011-1774-x","volume":"133","author":"Y Ma","year":"2012","unstructured":"Ma Y, Hao X, Zhang S, Zhang J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res Treat. 2012;133(2):473\u201385.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3334_CR49","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3892\/or.2016.4853","volume":"36","author":"M Li","year":"2016","unstructured":"Li M, Cai H, Yang Y, Zhang J, Sun K, Yan Y, et al. Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1\/Wnt\/beta-catenin signaling pathway. Oncol Rep. 2016;36(2):936\u201344.","journal-title":"Oncol Rep"},{"issue":"1","key":"3334_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-021-02809-2","volume":"19","author":"J Wu","year":"2021","unstructured":"Wu J, Xie S, Li H, Zhang Y, Yue J, Yan C, et al. Antitumor effect of IL-12 gene-modified bone marrow mesenchymal stem cells combined with Fuzheng Yiliu decoction in an in vivo glioma nude mouse model. J Transl Med. 2021;19(1):1\u201314.","journal-title":"J Transl Med"},{"issue":"1","key":"3334_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.1247","volume":"31","author":"IA Ho","year":"2013","unstructured":"Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, et al. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells. 2013;31(1):146\u201355.","journal-title":"Stem Cells"},{"key":"3334_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/5584_2019_464","volume":"1292","author":"N Zakaria","year":"2020","unstructured":"Zakaria N, Yahaya BH. Adipose-derived mesenchymal stem cells promote growth and migration of lung adenocarcinoma cancer cells. Adv Exp Med Biol. 2020;1292:83\u201395.","journal-title":"Adv Exp Med Biol"},{"issue":"20","key":"3334_CR53","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.3390\/cancers13205212","volume":"13","author":"T Luo","year":"2021","unstructured":"Luo T, von der Ohe J, Hass R. MSC-derived extracellular vesicles in tumors and therapy. Cancers (Basel). 2021;13(20):5212.","journal-title":"Cancers (Basel)."},{"issue":"5","key":"3334_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13402-017-0335-7","volume":"40","author":"K Pakravan","year":"2017","unstructured":"Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, et al. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR\/HIF-1alpha\/VEGF signaling axis in breast cancer cells. Cell Oncol (Dordr). 2017;40(5):457\u201370.","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"3334_CR55","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s10620-020-06458-1","volume":"66","author":"T Li","year":"2021","unstructured":"Li T, Wan Y, Su Z, Li J, Han M, Zhou C. Mesenchymal stem cell-derived exosomal microRNA-3940-5p inhibits colorectal cancer metastasis by targeting integrin alpha6. Dig Dis Sci. 2021;66(6):1916\u201327.","journal-title":"Dig Dis Sci"},{"issue":"4","key":"3334_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10719-019-09876-0","volume":"36","author":"RD Cummings","year":"2019","unstructured":"Cummings RD. Stuck on sugars\u2014how carbohydrates regulate cell adhesion, recognition, and signaling. Glycoconj J. 2019;36(4):241\u201357.","journal-title":"Glycoconj J"},{"issue":"6","key":"3334_CR57","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1084\/jem.20061929","volume":"204","author":"G An","year":"2007","unstructured":"An G, Wei B, Xia B, McDaniel JM, Ju T, Cummings RD, et al. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J Exp Med. 2007;204(6):1417\u201329.","journal-title":"J Exp Med"},{"key":"3334_CR58","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","volume":"10","author":"SR Stowell","year":"2015","unstructured":"Stowell SR, Ju T, Cummings RD. Protein glycosylation in cancer. Annu Rev Pathol. 2015;10:473\u2013510.","journal-title":"Annu Rev Pathol"},{"issue":"26","key":"3334_CR59","doi-asserted-by":"publisher","first-page":"16613","DOI":"10.1073\/pnas.262438199","volume":"99","author":"T Ju","year":"2002","unstructured":"Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc Natl Acad Sci U S A. 2002;99(26):16613\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3334_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.acr.2014.11.002","volume":"126","author":"MR Kudelka","year":"2015","unstructured":"Kudelka MR, Ju T, Heimburg-Molinaro J, Cummings RD. Simple sugars to complex disease\u2013mucin-type O-glycans in cancer. Adv Cancer Res. 2015;126:53\u2013135.","journal-title":"Adv Cancer Res"},{"key":"3334_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biochi.2019.07.015","volume":"165","author":"MY Jeon","year":"2019","unstructured":"Jeon MY, Seo SU, Woo SM, Min KJ, Byun HS, Hur GM, et al. Oridonin enhances TRAIL-induced apoptosis through GALNT14-mediated DR5 glycosylation. Biochimie. 2019;165:108\u201314.","journal-title":"Biochimie"},{"issue":"9","key":"3334_CR62","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/nm1627","volume":"13","author":"KW Wagner","year":"2007","unstructured":"Wagner KW, Punnoose EA, Januario T, Lawrence DA, Pitti RM, Lancaster K, et al. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L\/TRAIL. Nat Med. 2007;13(9):1070\u20137.","journal-title":"Nat Med"},{"issue":"25","key":"3334_CR63","doi-asserted-by":"publisher","first-page":"17157","DOI":"10.1074\/jbc.M109.010934","volume":"284","author":"SH Lee","year":"2009","unstructured":"Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama C, Khoo KH, et al. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem. 2009;284(25):17157\u201369.","journal-title":"J Biol Chem"},{"key":"3334_CR64","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/547501","volume":"2013","author":"D Bhartiya","year":"2013","unstructured":"Bhartiya D. Are mesenchymal cells indeed pluripotent stem cells or just stromal cells? OCT-4 and VSELs biology has led to better understanding. Stem Cells Int. 2013;2013: 547501.","journal-title":"Stem Cells Int"},{"issue":"4","key":"3334_CR65","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12015-018-9821-1","volume":"14","author":"R Lahlil","year":"2018","unstructured":"Lahlil R, Scrofani M, Barbet R, Tancredi C, Aries A, Henon P. VSELs maintain their pluripotency and competence to differentiate after enhanced ex vivo expansion. Stem Cell Rev Rep. 2018;14(4):510\u201324.","journal-title":"Stem Cell Rev Rep"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:02:34Z","timestamp":1685124154000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3334"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03334-3","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional research ethics committee of Binzhou Medical University (Project name: The influence of MSCs on the glycome and malignant behaviors of cancer cells; approval number: 2018-089; date of approval: June 10th, 2018). All of the participants in the study have been informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}